Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $58,745 - $80,673
322 New
322 $63,000
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $74,915 - $110,980
-367 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $93,772 - $132,894
367 New
367 $104,000
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $214,640 - $263,980
-576 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$222.0 - $252.62 $127,872 - $145,509
576 New
576 $144,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Standard Family Office LLC Portfolio

Follow Standard Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Standard Family Office LLC with notifications on news.